Identifying germline APOBEC3B deletion and immune phenotype in Korean patients with operable breast cancer.
Se Hyun KimSoomin AhnKoung Jin SuhYu Jung KimSo Yeon ParkEunyoung KangEun-Kyu KimIn Ah KimSumin ChaeMurim ChoiJee Hyun KimPublished in: Breast cancer research and treatment (2020)
We identified germline APOBEC3B deletion in 9.7% of Korean patients with operable breast cancer. The relationship between A3Bdel/del genotype and high TILs suggests that patients carrying this genotype could be potential candidates for immunotherapy.